Skip to main content
Watch Insiders
REPLHealthcare

Replimune Group Inc (REPL) Insider Trading

In the last 90 days, 4 Replimune Group Inc (REPL) insiders reported no open-market purchases and 5 sales totaling $1,038,364. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 17, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 17, 2026Emily Luisa HillChief Financial OfficerSale9,256$14.28$132,176
Aug 10, 2026Sushil PatelChief Executive OfficerSale39,341$12.97$510,253
Aug 10, 2026Emily Luisa HillChief Financial OfficerSale11,448$12.97$148,481
Aug 10, 2026Konstantinos XynosChief Medical OfficerSale11,447$12.97$148,468
Aug 10, 2026Andrew SchwendenmanChief Accounting OfficerSale7,632$12.97$98,987
Jun 1, 2026Christopher SarchiChief Commercial OfficerSale12,000$9.24$110,880
May 18, 2026Konstantinos XynosChief Medical OfficerSale14,023$5.08$71,237
May 18, 2026Andrew SchwendenmanChief Accounting OfficerSale7,894$5.08$40,102
May 18, 2026Christopher SarchiChief Commercial OfficerSale8,626$5.08$43,820
May 18, 2026Philip Astley-SparkeCorporate insiderSale17,657$5.08$89,698
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

REPL insider trading FAQ

Are REPL insiders buying or selling?
Over the last 90 days, REPL insiders were net sellers, reporting $0.00 of open-market purchases and $1,038,364 of sales.
When was the last REPL insider purchase?
No open-market insider purchase of Replimune Group Inc stock was reported in the last 90 days.
Where does REPL insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Replimune Group Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.